Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CURXCuranex Pharmaceuticals Inc

Nasdaq · CIK 0002025942
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts125

Identity from submissions API

NameCuranex Pharmaceuticals Inc
CIK0002025942
TickersCURX
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN830741390
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone718-673-6078
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
2 JERICHO PLAZA,
SUITE101B
JERICHO
NY
11753
NY
Mailing address
2 JERICHO PLAZA,
SUITE101B
JERICHO
NY
11753
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

66 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 10-Q 10-Q 0001493152-26-051628 001-42815 261550952 34 4006056 1 1
2026-10-19 S-8 S-8 0001493152-26-047616 333-299527 261469888 33 266145 1 1
2026-10-19 8-K 8-K 8.01 0001493152-26-047614 001-42815 261469881 34 206349 1 1
2026-09-04 8-K 8-K 8.01 0001493152-26-041546 001-42815 261362281 34 202061 1 1
2026-08-17 8-K 8-K 3.03,5.03,9.01 0001493152-26-038764 001-42815 261287286 34 2738501 1 1
2026-08-14 10-Q 10-Q 0001493152-26-038145 001-42815 261278618 34 3547683 1 1
2026-07-21 S-8 S-8 0001493152-26-034091 333-297597 261190521 33 456613 1 1
2026-06-29 DEF 14C DEF 14C 0001493152-26-030447 001-42815 261132247 34 319326
2026-06-18 PRE 14C PRE 14C 0001493152-26-029388 001-42815 261103986 34 319182
2026-05-14 8-K 8-K 7.01,9.01 0001493152-26-022898 001-42815 26976176 34 232483 1 1
2026-05-14 10-Q 10-Q 0001493152-26-022892 001-42815 26976045 34 2958789 1 1
2026-05-07 8-K 8-K 8.01 0001493152-26-021658 001-42815 26951802 34 206208 1 1
2026-04-02 8-K 8-K 7.01,9.01 0001493152-26-014815 001-42815 26830727 34 227817 1 1
2026-03-30 10-K 10-K 0001493152-26-013677 001-42815 26813904 34 18963513 1 1
2026-03-06 8-K 8-K 1.01,5.02,9.01 0001493152-26-009155 001-42815 26731498 34 463796 1 1
2026-01-05 8-K 8-K 5.02,9.01 0001493152-26-000358 001-42815 26505611 34 251184 1 1
2025-11-17 10-Q 10-Q 0001493152-25-023710 001-42815 251489143 34 3234611 1 1
2025-11-17 NT 10-Q NT 10-Q 0001493152-25-023703 001-42815 251489069 34 34233
2025-11-06 8-K 8-K 3.01 0001493152-25-021028 001-42815 251457345 34 209041 1 1
2025-09-29 8-K 8-K 3.02,8.01,9.01 0001493152-25-015986 001-42815 251355928 34 214324 1 1
2025-09-12 8-K 8-K 8.01,9.01 0001493152-25-013167 001-42815 251311171 34 244476 1 1
2025-09-09 10-Q 10-Q 0001493152-25-012880 001-42815 251302999 34 2968471 1 1
2025-09-02 3 3 0001641172-25-026284 2947
2025-09-02 3 3 0001641172-25-026281 2948
2025-09-02 3 3 0001641172-25-026282 2971
2025-09-02 3 3 0001641172-25-026287 2935
2025-09-02 3 3 0001641172-25-026283 7451
2025-09-02 3 3 0001641172-25-026286 2944
2025-09-02 3 3 0001641172-25-026285 2965
2025-09-02 3 3 0001641172-25-026279 6342
2025-09-02 3 3 0001641172-25-026280 7548
2025-08-27 8-K 8-K 8.01,9.01 0001493152-25-012404 001-42815 251266319 34 244999 1 1
2025-08-26 424B4 424B4 0001493152-25-012351 333-282686 251258844 33 8599506
2025-08-26 424B4 424B4 0001493152-25-012350 333-282686 251258826 33 8733493
2025-08-26 8-K 8-K 1.01,8.01,9.01 0001493152-25-012316 001-42815 251252619 34 672447 1 1
2025-08-25 CERT 8A_CERT_CURX.pdf 0001354457-25-000847 001-42815 251250238 34 123074
2025-08-25 8-A12B 8-A12B 0001493152-25-012296 001-42815 251248570 34 22507
2025-08-12 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002569 333-282686 251208743 33 1754
2025-08-08 CORRESP filename1.htm 0001493152-25-011767 13591
2025-08-08 CORRESP filename1.htm 0001493152-25-011762 13690
2025-07-22 FWP FWP 0001641172-25-020593 333-282686 251140741 34 3732174
2025-07-18 S-1/A S-1/A 0001641172-25-020262 333-282686 251135065 33 9344682
2025-07-10 FWP FWP 0001641172-25-018580 333-282686 251116243 34 29509126
2025-07-01 S-1/A S-1/A 0001641172-25-017373 333-282686 251097024 33 9552152 1 1
2025-04-09 CORRESP filename1.htm 0001641172-25-003441 13057
2025-04-08 CORRESP filename1.htm 0001641172-25-003150 13662
2025-04-08 CORRESP filename1.htm 0001641172-25-003130 14110
2025-03-19 FWP formfwp.htm 0001641172-25-000025 333-282686 25753287 34 11576946
2025-03-17 CORRESP filename1.htm 0001493152-25-010522 31021
2025-03-17 S-1/A forms-1a.htm 0001493152-25-010520 333-282686 25743276 33 9395294
2025-02-21 UPLOAD filename1.pdf 0000000000-25-002048 377-07290 43032
2025-02-14 S-1/A forms-1a.htm 0001493152-25-006655 333-282686 25625150 33 9594871
2024-11-27 S-1/A forms-1a.htm 0001493152-24-048072 333-282686 241512587 33 18255469
2024-11-01 CORRESP filename1.htm 0001493152-24-043387 35058
2024-11-01 S-1/A forms-1a.htm 0001493152-24-043386 333-282686 241420137 33 9871234
2024-10-28 UPLOAD filename1.pdf 0000000000-24-012014 377-07290 46186
2024-10-16 S-1 forms-1.htm 0001493152-24-041335 333-282686 241375453 33 29622937
2024-10-16 CORRESP filename1.htm 0001493152-24-041337 27480
2024-09-23 UPLOAD filename1.pdf 0000000000-24-010778 377-07290 44639
2024-09-16 DRS/A filename1.htm 0001493152-24-036252 377-07290 241299043 33 9005530
2024-09-13 DRSLTR filename1.htm 0001493152-24-036254 38246
2024-08-28 UPLOAD filename1.pdf 0000000000-24-009821 377-07290 48821
2024-08-15 DRS/A filename1.htm 0001493152-24-032472 377-07290 241210431 33 8996741
2024-08-14 DRSLTR filename1.htm 0001493152-24-032474 103843
2024-07-17 UPLOAD filename1.pdf 0000000000-24-008116 377-07290 71643
2024-06-20 DRS filename1.htm 0001493152-24-024532 377-07290 241056751 33 25311488

Latest XBRL company facts

One latest value per concept from companyfacts (125 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 1.57M 2026-11-13 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-03-30 0001493152-26-013677
ffd NetFeeAmt NetFeeAmt USD 57.32 2026-10-19 S-8 2026-10-19 0001493152-26-047616
ffd TtlFeeAmt TtlFeeAmt USD 57.32 2026-10-19 S-8 2026-10-19 0001493152-26-047616
ffd TtlOfferingAmt TtlOfferingAmt USD 658,800 2026-10-19 S-8 2026-10-19 0001493152-26-047616
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-19 S-8 2026-10-19 0001493152-26-047616
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2,426 2025-12-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 9,741 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 9,741 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap AccruedPayrollTaxesCurrentAndNoncurrent Accrued Payroll Taxes USD 9,741 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 550 2025-06-30 2025 Q2 10-Q 2025-09-09 0001493152-25-012880
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 550 2025-12-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap AccruedRentCurrent Accrued Rent, Current USD 1,599 2025-12-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 16.65M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 154,009 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap Assets Assets USD 3.10M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap AssetsCurrent Assets, Current USD 2.56M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap Cash Cash USD 1.58M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 1.58M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 1.58M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -3.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -40,029 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-09-09 0001493152-25-012880
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 475.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 200,000 2019-12-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap CommonStockValue Common Stock, Value, Issued USD 157 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.043 2025-05-31 2025 FY 10-K 2026-03-30 0001493152-26-013677
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.043 2025-05-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 2.96M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 171,652 2025-06-30 2025 Q2 10-Q 2025-09-09 0001493152-25-012880
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 2.96M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap DeferredTaxAssetsOtherTaxCarryforwards Deferred Tax Assets, Other Tax Carryforwards USD 2,056 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 2.96M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap DividendsAndInterestPaid Dividends and Interest Paid USD 8,537.32 2025-09-01 2025-09-30 2026 Q1 10-Q 2026-05-14 0001493152-26-022892
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -6.38 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -6.38 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.051 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-038145
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 2.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -1.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -2,426 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -2,174 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 4,447 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-038145
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -100,167 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 228,321 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-038145
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -5.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap InterestCostsIncurred Interest Costs Incurred USD 4,447 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-09-09 0001493152-25-012880
us-gaap InterestExpense Interest Expense USD -4,447 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-038145
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 8,537 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 8,537.32 2025-09-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap InterestPayableCurrent Interest Payable, Current USD 4,447 2025-06-30 2025 Q2 10-Q 2025-09-09 0001493152-25-012880
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 599,389 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four USD 43,384 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-022892
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three USD 81,969 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-022892
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two USD 89,964 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-022892
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 117,412 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-022892
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 154,008 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 53,704 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 69,982 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 129,022 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 154,330 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 38,343 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 57,299 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap Liabilities Liabilities USD 551,831 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 3.10M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap LiabilitiesCurrent Liabilities, Current USD 143,300 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 400,000 2025-06-30 2025 Q2 10-Q 2025-09-09 0001493152-25-012880
us-gaap ManagementFeePayable Management Fee Payable USD 100,000 2024-10-03 2025 FY 10-K 2026-03-30 0001493152-26-013677
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 15.31M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -3.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -9.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OperatingExpenses Operating Expenses USD 9.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -9.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 120,216 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 542,090 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 133,559 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 408,531 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 540,622 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 107,552 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.049 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 14.10M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 74,676 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013677
us-gaap OtherAssetsCurrent Other Assets, Current USD 367,865 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013677
us-gaap OtherCommitment Other Commitment USD 65,000 2025-06-30 2025 FY 10-K 2026-03-30 0001493152-26-013677
us-gaap OtherGeneralExpense Other General Expense USD 74,676 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013677
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 81,832 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 314,783 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 2.98M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 25.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 100 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 976,701 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap PrepaidInsurance Prepaid Insurance USD 125,538 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 15.66M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 630,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013677
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 200,000 2025-05-01 2025-05-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 100 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013677
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 400,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-038145
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 6.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -14.10M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 163,801 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.9 2026-08-07 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 573,100 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 2.55M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 4.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013677
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 80,000 2026-08-07 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 573,100 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 14.94M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 100 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013677
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 9,792 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 25 2025-06-30 2025 Q2 10-Q 2025-09-09 0001493152-25-012880
us-gaap TaxesPayableCurrentAndNoncurrent Taxes Payable USD 25 2025-12-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 1.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051628

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →